SONM (DNA X, Inc. Common Stock) Stock Analysis - News
DNA X, Inc. Common Stock (SONM) is a publicly traded Technology sector company. As of May 21, 2026, SONM trades at $4.08 with a market cap of $6.94M and a P/E ratio of -0.16. SONM moved +0.00% today. Year to date, SONM is +45.96%; over the trailing twelve months it is -75.35%. Its 52-week range spans $2.52 to $114.84. Rallies surfaces SONM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What changed in SONM news today?
DNA X nets $6.3 million in Q1 from $15 million asset sale, repays debt: DNA X sold its mobile device business to NEXA Mobility for $15 million, netting $6.3 million in Q1 and using $12 million of proceeds to repay debt. It ended the quarter with $1.2 million cash and has arranged $1.8 million in new debt to fund its planned AI trading platform launch.
LYTTON LAURENCE W sold 400.51K (~$556.71K) on Jun 30, 2025.
LYTTON LAURENCE W sold 466.40K (~$699.60K) on Jun 26, 2025.
Becher Charles sold 31.33K (~$45.42K) on Apr 23, 2025.
SONM Analyst Consensus
SONM analyst coverage data. Average price target: $0.00.
Common questions about SONM
What changed in SONM news today?
DNA X nets $6.3 million in Q1 from $15 million asset sale, repays debt: DNA X sold its mobile device business to NEXA Mobility for $15 million, netting $6.3 million in Q1 and using $12 million of proceeds to repay debt. It ended the quarter with $1.2 million cash and has arranged $1.8 million in new debt to fund its planned AI trading platform launch.
Does Rallies summarize SONM news?
Yes. Rallies summarizes SONM news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is SONM research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SONM. It does not provide personalized investment advice.
